Royal Bank of Canada Has $10.90 Million Stake in Calumet, Inc. $CLMT

Royal Bank of Canada lowered its stake in Calumet, Inc. (NASDAQ:CLMT) by 4.4% in the 1st quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 303,484 shares of the oil and gas company’s stock after selling 13,844 shares during the quarter. Royal Bank of Canada owned 0.35% of Calumet worth $10,896,000 at the end of the most recent reporting period.

Other institutional investors also recently modified their holdings of the company. Islay Capital Management LLC acquired a new stake in Calumet in the fourth quarter worth $25,000. Aster Capital Management DIFC Ltd raised its holdings in shares of Calumet by 294.7% during the fourth quarter. Aster Capital Management DIFC Ltd now owns 1,646 shares of the oil and gas company’s stock valued at $33,000 after purchasing an additional 1,229 shares during the period. Global Retirement Partners LLC acquired a new position in shares of Calumet during the fourth quarter valued at about $34,000. Covestor Ltd boosted its position in shares of Calumet by 29.1% during the 4th quarter. Covestor Ltd now owns 2,180 shares of the oil and gas company’s stock worth $43,000 after purchasing an additional 492 shares in the last quarter. Finally, Advisory Services Network LLC bought a new position in shares of Calumet during the 3rd quarter worth about $59,000. Institutional investors and hedge funds own 34.41% of the company’s stock.

Calumet Trading Down 5.7%

Calumet stock opened at $39.48 on Friday. The firm has a market capitalization of $3.44 billion, a price-to-earnings ratio of -25.47 and a beta of 0.71. The firm’s fifty day moving average price is $37.98 and its two-hundred day moving average price is $32.63. Calumet, Inc. has a 1-year low of $12.94 and a 1-year high of $45.20.

Calumet (NASDAQ:CLMT) last posted its earnings results on Friday, August 7th. The oil and gas company reported ($1.09) EPS for the quarter, missing the consensus estimate of $0.07 by ($1.16). The firm had revenue of $1.45 billion for the quarter, compared to the consensus estimate of $1.12 billion. During the same period in the previous year, the firm posted ($1.70) earnings per share. Calumet’s quarterly revenue was up 40.8% compared to the same quarter last year. On average, research analysts forecast that Calumet, Inc. will post -0.13 EPS for the current year.

Calumet News Summary

Here are the key news stories impacting Calumet this week:

• Positive Sentiment: Calumet reported second-quarter adjusted EBITDA with tax attributes of $175.2 million, up from $76.5 million a year earlier. Its Specialty Products and Solutions segment delivered particularly strong results, with adjusted EBITDA rising to $161.7 million from $66.8 million. Calumet Reports Second Quarter 2026 Results
• Positive Sentiment: Management said Montana Renewables completed the first phase of its MaxSAF® 150 expansion and is capturing robust renewable-fuel margins. The company also retired $115 million of debt in July, supporting its deleveraging strategy. Calumet Reports Second Quarter 2026 Results
• Neutral Sentiment: Revenue jumped 40.8% year over year to $1.45 billion, exceeding the $1.12 billion analyst consensus. However, the revenue beat was overshadowed by weaker-than-expected profitability. Calumet Earnings Report
• Neutral Sentiment: Brokerages maintain a consensus “Hold” recommendation, suggesting analysts see limited near-term conviction following the results. Calumet Given Consensus Hold Recommendation
• Negative Sentiment: Calumet posted a second-quarter net loss of $95.9 million, or $1.09 per share, missing the $0.07-per-share consensus estimate by $1.16. The loss was driven largely by non-cash RIN and other mark-to-market items, while Montana/Renewables still reported a GAAP gross loss. Calumet Reports Second Quarter 2026 Results

Insider Activity at Calumet

In related news, major shareholder Group Heritage sold 626,998 shares of the company’s stock in a transaction on Friday, May 15th. The stock was sold at an average price of $32.54, for a total transaction of $20,402,514.92. Following the completion of the sale, the insider owned 12,980,211 shares in the company, valued at approximately $422,376,065.94. This represents a 4.61% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, Director Daniel J. Sajkowski sold 4,240 shares of the stock in a transaction on Wednesday, July 1st. The shares were sold at an average price of $36.16, for a total value of $153,318.40. Following the completion of the sale, the director directly owned 77,718 shares of the company’s stock, valued at $2,810,282.88. The trade was a 5.17% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 3.15% of the company’s stock.

Analysts Set New Price Targets

CLMT has been the subject of a number of research analyst reports. Weiss Ratings raised Calumet from a “sell (e+)” rating to a “sell (d-)” rating in a research report on Monday, May 11th. TD Cowen reiterated a “hold” rating on shares of Calumet in a report on Wednesday, June 3rd. Finally, The Goldman Sachs Group raised their price objective on Calumet from $36.00 to $40.00 and gave the company a “neutral” rating in a research note on Thursday, July 30th. One analyst has rated the stock with a Buy rating, four have given a Hold rating and one has assigned a Sell rating to the stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and an average target price of $37.75.

About Calumet

Calumet Specialty Products Partners, L.P. (NASDAQ: CLMT) is an independent provider of high-value, essential product solutions derived from both petroleum and renewable feedstocks. The company operates an integrated network of manufacturing plants, blending terminals and storage facilities across North America, delivering customized products and technical services to industrial, automotive, consumer and agricultural end markets. By leveraging its scale and technical expertise, Calumet tailors supply chain and formulation solutions to meet stringent regulatory and performance requirements.

Calumet’s product portfolio includes specialty lubricants and base oils for high-performance applications; process oils and waxes for food-grade, cosmetic and packaging uses; industrial solvents and cleaning solutions; and fuel additives designed to optimize engine performance and emissions.